Item Type | Name |
Concept
|
Migraine Disorders
|
Concept
|
Migraine with Aura
|
Concept
|
Migraine without Aura
|
Academic Article
|
MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
|
Academic Article
|
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments.
|
Academic Article
|
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia.
|
Academic Article
|
AVP-825 Breath-Powered Intranasal Delivery System Containing 22?mg Sumatriptan Powder vs 100?mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks.
|
Academic Article
|
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
|
Academic Article
|
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.
|
Academic Article
|
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).
|
Academic Article
|
Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.
|
Academic Article
|
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.
|
Academic Article
|
The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings.
|
Academic Article
|
The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort.
|
Academic Article
|
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
|
Academic Article
|
Role of melatonin in the pathophysiology of migraine: implications for treatment.
|
Academic Article
|
Tinnitus in migraine: an allodynic symptom secondary to abnormal cortical functioning?
|
Academic Article
|
Editorial: Understanding Menstrual Migraine.
|
Academic Article
|
Chronic daily headache: identification of factors associated with induction and transformation.
|
Academic Article
|
Tailoring management strategies for the patient with menstrual migraine: focus on prevention and treatment.
|
Academic Article
|
Acute treatment of basilar-type migraine with greater occipital nerve blockade.
|
Academic Article
|
A pivotal moment in 50 years of headache history: the first American Migraine Study.
|
Academic Article
|
The role of prevention.
|
Academic Article
|
Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation.
|
Academic Article
|
Revisiting the role of ergots in the treatment of migraine and headache.
|
Academic Article
|
A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine.
|
Academic Article
|
Editorial: Nutraceuticals and Occipital Nerve Blocks.
|
Academic Article
|
Menstrual Migraine and Treatment Options-A Response.
|
Academic Article
|
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
|
Academic Article
|
New paradigms in the recognition and acute treatment of migraine.
|
Academic Article
|
Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool.
|
Academic Article
|
The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.
|
Academic Article
|
Antiepilepsy Drugs in Migraine Prevention: Editorial.
|
Academic Article
|
Opioids should not be used in migraine.
|
Academic Article
|
Structural and functional neuroimaging in migraine: insights from 3 decades of research.
|
Academic Article
|
Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective.
|
Academic Article
|
Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study.
|
Academic Article
|
Vascular safety of erenumab for migraine prevention.
|
Academic Article
|
New migraine preventive options: an update with pathophysiological considerations.
|
Academic Article
|
Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine.
|
Academic Article
|
Treatment of menstrual migraine: evidence-based review.
|
Academic Article
|
Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine.
|
Academic Article
|
The triptan formulations : how to match patients and products.
|
Academic Article
|
Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety.
|
Academic Article
|
Safety profile of the triptans.
|
Academic Article
|
Reliability, validity, and clinical utility of the Migraine-ACT questionnaire.
|
Academic Article
|
Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
|
Academic Article
|
Assessment of adverse events associated with triptans--methods of assessment influence the results.
|
Academic Article
|
History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
|
Academic Article
|
Sumatriptan: a decade of use and experience in the treatment of migraine.
|
Academic Article
|
Iron deposition in pain-regulatory nuclei in episodic migraine and chronic daily headache by MRI.
|
Academic Article
|
Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine.
|
Academic Article
|
Frequency of Migraine Headaches in Patients With Fibromyalgia.
|
Academic Article
|
Chronic migraine and medication overuse headache.
|
Academic Article
|
Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden.
|
Academic Article
|
Treatment persistence and switching in triptan users: a systematic literature review.
|
Academic Article
|
Breath-powered sumatriptan dry nasal powder: an intranasal medication delivery system for acute treatment of migraine.
|
Academic Article
|
Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.
|
Academic Article
|
Rejection and acceptance of possible side effects of migraine prophylactic drugs.
|
Academic Article
|
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.
|
Academic Article
|
Mechanisms of action of the 5-HT1B/1D receptor agonists.
|
Academic Article
|
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
|
Academic Article
|
Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
|
Academic Article
|
Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks.
|
Academic Article
|
Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients.
|
Academic Article
|
Adherence to acute migraine medication: what does it mean, why does it matter?
|
Academic Article
|
Burden of migraine in Brazil: estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care.
|
Academic Article
|
Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases.
|
Academic Article
|
Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
|
Academic Article
|
Hemicrania continua: a report of ten new cases.
|
Academic Article
|
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
|
Academic Article
|
Ergotamine and dihydroergotamine: a review.
|
Academic Article
|
Expert opinion: Rescue me: rescue medication for migraine.
|
Academic Article
|
Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine.
|
Academic Article
|
Cyclic vomiting syndrome, inborn errors of metabolism, migraine variants, episodic syndromes that may be associated with migraine, and other unusual pediatric headache syndromes.
|
Academic Article
|
Early onset of efficacy with erenumab in patients with episodic and chronic migraine.
|
Academic Article
|
Acute Treatment of Migraine.
|
Academic Article
|
Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study.
|
Academic Article
|
Ictal adiponectin levels in episodic migraineurs: a randomized pilot trial.
|
Academic Article
|
Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study.
|
Academic Article
|
The effect of weather on headache.
|
Academic Article
|
Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
|
Academic Article
|
Recent studies on PFO and migraine: is there a future for closure?
|
Academic Article
|
Levetiracetam in the preventive treatmentof transformed migraine: A prospective, open-label, pilot study.
|
Academic Article
|
Menstrual Migraine and Treatment Options: Review.
|
Academic Article
|
An overview of migraine pathophysiology.
|
Academic Article
|
Zolmitriptan (Zomig).
|
Academic Article
|
Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period.
|
Academic Article
|
Orally inhaled dihydroergotamine: a review.
|
Academic Article
|
Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine.
|
Academic Article
|
Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials.
|
Academic Article
|
QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 1: review of serotonergic cardiac adverse events with a triptan case.
|
Academic Article
|
Intranasal zolmitriptan for the treatment of acute migraine.
|
Academic Article
|
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points.
|
Academic Article
|
Patent Foramen Ovale and Migraine: Closing the Debate--A Review.
|
Academic Article
|
Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study.
|
Academic Article
|
Sumatriptan/naproxen sodium combination for the treatment of migraine.
|
Academic Article
|
Outcome for headache and pain-free nonresponders to treatment of the first attack: a pooled post-hoc analysis of four randomized trials of eletriptan 40 mg.
|
Academic Article
|
Memantine in the preventive treatment of refractory migraine.
|
Academic Article
|
An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
|
Academic Article
|
Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial.
|
Academic Article
|
Acute treatment of migraines.
|
Academic Article
|
Intranasal medications for the treatment of migraine and cluster headache.
|
Academic Article
|
Dihydroergotamine and its use in migraine with posterior fossa symptoms.
|
Academic Article
|
Clinical implications for breath-powered powder sumatriptan intranasal treatment.
|
Academic Article
|
Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
|
Academic Article
|
Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.
|
Academic Article
|
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
|
Academic Article
|
Real-world Experience with Remote Electrical Neuromodulation in the Acute Treatment of Migraine.
|
Academic Article
|
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2.
|
Academic Article
|
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study.
|
Academic Article
|
Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial.
|
Academic Article
|
Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study.
|
Academic Article
|
A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN.
|
Academic Article
|
A narrative review of the importance of pharmacokinetics and drug-drug interactions of preventive therapies in migraine management.
|
Academic Article
|
Breaking the cycle of medication overuse headache.
|
Academic Article
|
Risk of medication overuse headache across classes of treatments for acute migraine.
|
Academic Article
|
Pharmacologic management of migraine.
|
Academic Article
|
Timing and durability of response to erenumab in patients with chronic migraine.
|
Academic Article
|
Risk of hypertension in erenumab-treated patients with migraine: Analyses of clinical trial and postmarketing data.
|
Academic Article
|
Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States.
|
Academic Article
|
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials.
|
Academic Article
|
Migraine--the forgotten epidemic: development of the EHF/WHA Rome Declaration on Migraine.
|
Academic Article
|
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura.
|
Academic Article
|
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache.
|
Academic Article
|
Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2-4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER).
|
Academic Article
|
Unusual headaches in the elderly.
|
Academic Article
|
Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2-4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER).
|
Academic Article
|
Erenumab dosage for migraine prevention: An evidence-based narrative review with recommendations.
|
Academic Article
|
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials.
|
Academic Article
|
CGRP and headache: a brief review.
|
Academic Article
|
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis.
|
Academic Article
|
Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM).
|
Academic Article
|
External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial.
|
Academic Article
|
Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A randomized controlled trial.
|
Academic Article
|
Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure.
|
Academic Article
|
Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative Review.
|
Academic Article
|
Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trial.
|
Academic Article
|
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial.
|
Academic Article
|
Novel Migraine Treatments: A Review.
|
Academic Article
|
Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION-A phase 4, multinational, randomized, double-blind, placebo-controlled study.
|
Academic Article
|
The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression.
|
Academic Article
|
Sustained response of galcanezumab in migraine prevention: Patient-level data from a post hoc analysis in patients with episodic or chronic migraine.
|
Academic Article
|
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
|
Academic Article
|
A Brief Review of Gepants.
|
Academic Article
|
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review.
|
Academic Article
|
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non-interventional study using claims data from the United States.
|
Academic Article
|
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
|
Academic Article
|
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study.
|
Academic Article
|
Management of medication overuse headache.
|
Academic Article
|
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks.
|
Academic Article
|
Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies.
|
Academic Article
|
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial.
|
Academic Article
|
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study.
|
Academic Article
|
Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures.
|